Allergan gets subpoena on Botox promotion
NEW YORK (Reuters) - Allergan Inc said on Monday that it received a subpoena from the U.S. Department of Justice investigating the promotion of Botox, a drug best known for its cosmetic use.
<p><img src="http://feeds.reuters.com/~a/Reuters/domesticNews?i=tfuL2k" border="0"></img> (http://feeds.reuters.com/~a/Reuters/domesticNews?a=tfuL2k)</p><div class="feedflare">
<img src="http://feeds.reuters.com/~f/Reuters/domesticNews?i=nqgn0BF" border="0"></img> (http://feeds.reuters.com/~f/Reuters/domesticNews?a=nqgn0BF) <img src="http://feeds.reuters.com/~f/Reuters/domesticNews?i=tzzjHMf" border="0"></img> (http://feeds.reuters.com/~f/Reuters/domesticNews?a=tzzjHMf) <img src="http://feeds.reuters.com/~f/Reuters/domesticNews?i=pbLkkmf" border="0"></img> (http://feeds.reuters.com/~f/Reuters/domesticNews?a=pbLkkmf)
</div><img src="http://feeds.reuters.com/~r/Reuters/domesticNews/~4/245245199" height="1" width="1"/>
http://feeds.reuters.com/~r/Reuters/domesticNews/~3/245245199/idUSWEN430320080304